Home
ES ES

Financial Documentation

Financial Information

2022 First half financial results communication

Year-end 2021 financial results and corporate structure report

Annual Report 2021

BME Growth Communications

Information regarding acquisitions 

Information regarding acquisition

Information regarding Sngular’s acquisition of Corunet.

Other relevant information

Parenclitic- Sngular Holder Absorption Fusion

Transactions completed by Parenclitic

Notice of operations by Sngular executives

Notice of operations by Sngular executives

Transactions completed by Parenclitic

Changes in the Board of Directors

Transactions completed by Parenclitic

Transactions completed by Parenclitic

Transactions completed by Parenclitic

Integration of Atlera

Transactions completed by Parenclitic

Stock buyback program

Major shareholders

Transactions completed by Parenclitic

Transactions completed by Parenclitic

Major shareholders

Stock buyback program

Stock buyback program

Notice of operations by Sngular executives

Resolutions adopted at the Ordinary General Shareholders' Meeting

Medcap 2022 Forum Presentation

2022 Ordinary General Shareholders' Meeting Presentation

Notice of Ordinary General Shareholders Meeting

Communication operations administrator subsidiary Group Sngular

Notice of operations by Sngular executives

Purchase and sale by Sngular executives and updated major shareholder holdings

Notice of operations by Sngular executives

Notice of relevant facts

Major shareholders

Notice of relevant facts

Major shareholders

Integration of Acilia

Major shareholders

Major shareholders

Notice of relevant facts

Costs of IPO

© Copyright - Sngular 2022

Privacy & Conditions